Ebola To Hit 20,000 People By End Of Year

Actions
Ebola To Hit 20,000 People By End Of Year
Susan J.

Lopinion by

Susan J.

Aug 31, 2014

According to health agencies, the Ebola virus is slated to spread to 20,000 in just 9 months.

According to the WHO, cases of the Ebola virus are skyrocketing with a first case spreading to a fifth country in West Africa. Meanwhile, two U.S. health workers who volunteered to help in West Africa have been flown back to the Center for Disease Control in Atlanta after exhibiting symptoms of Ebola.

Both the U.S. government and the Center for Disease Control and Prevention have warned, traveling to West Africa is on highest response level alert and advised against it, reported the Wall Street Journal.

Although some of the symptoms for Ebola appears to be general in nature as you would find in a fever, death from Ebola is caused by internal hemmhoraging. There is not much health care givers can do in the form of treatment of Ebola, except buffer up immunity to resist infections, fever and secondary bacterial infections. Vaccines have not been successful in humans, but have found to work in six-month period injects for other primates.

The Regulatory Affairs Professionals Society said, "In the United States, the FDA's animal efficacy rule is being used to demonstrate reasonable safety to obtain permission to treat people who are infected with Ebola. It is being used as the normal path for testing drugs is not possible for diseases caused by dangerous pathogens or toxins," cites sources close to the story.

"Experimental drugs are made available for use with the approval of regulatory agencies under named patient programs, known in the US as "expanded access". The FDA has allowed two drugs, ZMapp and an RNA interference drug called TKM-Ebola, to be used in people infected with Ebola under these programs during the 2014 outbreak," the New York Times reported.

source: YouTube

Keywords:

Comments (1)

You must Register or Login to post a comment

1000 Characters left

Copyright © GLBrain 2024. All rights reserved.